These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18827255)

  • 1. Factor XI mutation and the origin of Ashkenazi Jews.
    Zoossmann-Diskin A
    Haematologica; 2008 Oct; 93(10):e59; discussion e60. PubMed ID: 18827255
    [No Abstract]   [Full Text] [Related]  

  • 2. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews.
    Shpilberg O; Peretz H; Zivelin A; Yatuv R; Chetrit A; Kulka T; Stern C; Weiss E; Seligsohn U
    Blood; 1995 Jan; 85(2):429-32. PubMed ID: 7811996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two common mutations causing factor XI deficiency in Ashkenazi Jews may point to a European origin.
    Zoossmann-Diskin A
    Blood; 1995 Oct; 86(8):3267-8. PubMed ID: 7579427
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor XI Deficiency.
    Duga S; Salomon O
    Semin Thromb Hemost; 2009 Jun; 35(4):416-25. PubMed ID: 19598070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four novel FXI gene mutations in three factor XI- deficient patients.
    de Raucourt E; de Mazancourt P; Quélin F
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):240-2. PubMed ID: 18388506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews.
    Peretz H; Salomon O; Mor-Cohen R; Usher S; Zucker M; Zivelin A; Seligsohn U
    J Thromb Haemost; 2013 Apr; 11(4):724-30. PubMed ID: 23332144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.
    Asakai R; Chung DW; Ratnoff OD; Davie EW
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7667-71. PubMed ID: 2813350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XI deficiency.
    Gomez K; Bolton-Maggs P
    Haemophilia; 2008 Nov; 14(6):1183-9. PubMed ID: 18312365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe factor XI deficiency in a Korean woman with a novel missense mutation (Val498Met) and duplication G mutation in exon 13 of the F11 gene.
    Kwon MJ; Kim HJ; Bang SH; Kim SH
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):679-83. PubMed ID: 18832909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging-related occurrence in Ashkenazi Jews of leukocyte heteroplasmic mtDNA mutation adjacent to replication origin frequently remodeled in Italian centenarians.
    Iwata N; Zhang J; Atzmon G; Leanza S; Cho J; Chomyn A; Burk RD; Barzilai N; Attardi G
    Mitochondrion; 2007 Jul; 7(4):267-72. PubMed ID: 17452024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the structural effects of four novel and a previously known mutations causing factor XI deficiency.
    Spena S; Asselta R; Caccia S; Rimoldi V; Giacomelli SH; Tagliaferri A; Peyvandi F; Castaman G; Duga S
    Thromb Haemost; 2009 Sep; 102(3):603-6. PubMed ID: 19718484
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe factor XI deficiency in the Abruzzo region of Italy is associated to different FXI gene mutations.
    Castaman G; Giacomelli SH; Dragani A; Iuliani O; Duga S; Rodeghiero F
    Haematologica; 2008 Jun; 93(6):957-8. PubMed ID: 18515884
    [No Abstract]   [Full Text] [Related]  

  • 13. [Congenital deficiency of factor XI].
    Nagao T
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):445-8. PubMed ID: 9833539
    [No Abstract]   [Full Text] [Related]  

  • 14. Bleeding disorders in Ashkenazi Jews.
    Malnick SD
    Postgrad Med; 1991 Jul; 90(1):40, 42. PubMed ID: 2062762
    [No Abstract]   [Full Text] [Related]  

  • 15. First diagnosis of factor XI deficiency in a patient with subarachnoid haemorrhage.
    Vasileiadis I; El-Ali M; Nanas S; Kolias S; Zacharatos P; Christopoulou-Cokkinou V; Kotanidou A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):309-13. PubMed ID: 19367158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolonged activated partial thromboplastin time (aPTT): not always indicative of increased risk of bleeding].
    van der Pas AJ; Leebeek FW; Perry DJ; Castel A; van Esser JW
    Ned Tijdschr Geneeskd; 2009; 153():B42. PubMed ID: 19785809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XI in haemostasis and thrombosis: past, present and future.
    Seligsohn U
    Thromb Haemost; 2007 Jul; 98(1):84-9. PubMed ID: 17597996
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial DNA control region variation in Ashkenazi Jews from Hungary.
    Brandstätter A; Egyed B; Zimmermann B; Tordai A; Padar Z; Parson W
    Forensic Sci Int Genet; 2008 Jan; 2(1):e4-6. PubMed ID: 19083780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XI gene mutations in factor XI deficient patients of the Czech Republic.
    Castaman G; Giacomelli SH; Habart D; Asselta R; Duga S; Rodeghiero F
    Am J Hematol; 2008 Dec; 83(12):916-9. PubMed ID: 18839438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.